Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.84 USD
−17.98 M USD
0.00 USD
6.95 M
About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of COCP is 2.25 USD — it has increased by 7.14% in the past 24 hours. Watch Cocrystal Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cocrystal Pharma, Inc. stocks are traded under the ticker COCP.
COCP stock has risen by 22.95% compared to the previous week, the month change is a 13.07% rise, over the last year Cocrystal Pharma, Inc. has showed a 17.19% increase.
We've gathered analysts' opinions on Cocrystal Pharma, Inc. future price: according to them, COCP price has a max estimate of 10.00 USD and a min estimate of 7.00 USD. Watch COCP chart and read a more detailed Cocrystal Pharma, Inc. stock forecast: see what analysts think of Cocrystal Pharma, Inc. and suggest that you do with its stocks.
COCP reached its all-time high on May 20, 2011 with the price of 1,981.98 USD, and its all-time low was 1.33 USD and was reached on Feb 20, 2024. View more price dynamics on COCP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
COCP stock is 15.32% volatile and has beta coefficient of −0.02. Track Cocrystal Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Cocrystal Pharma, Inc. there?
Today Cocrystal Pharma, Inc. has the market capitalization of 22.89 M, it has increased by 5.32% over the last week.
Yes, you can track Cocrystal Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
Cocrystal Pharma, Inc. is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
COCP earnings for the last quarter are −0.49 USD per share, whereas the estimation was −0.57 USD resulting in a 14.04% surprise. The estimated earnings for the next quarter are −0.56 USD per share. See more details about Cocrystal Pharma, Inc. earnings.
Cocrystal Pharma, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
COCP net income for the last quarter is −4.94 M USD, while the quarter before that showed −5.34 M USD of net income which accounts for 7.56% change. Track more Cocrystal Pharma, Inc. financial stats to get the full picture.
No, COCP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 23, 2024, the company has 12.00 employees. See our rating of the largest employees — is Cocrystal Pharma, Inc. on this list?
Like other stocks, COCP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cocrystal Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cocrystal Pharma, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cocrystal Pharma, Inc. stock shows the neutral signal. See more of Cocrystal Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.